Cerebral Therapeutics
Aurora, US · Delaware corporation · 4 known investors
Find your way into Cerebral Therapeutics
Sign up to see every warm intro you have to Cerebral Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cerebral Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DA
Daniel AbramsChief Executive Officer
WL

SF
Stephen FarrNamed on SEC filing
MS
Investors · 4
Granite Point Capitalreported
How we know: funding news · press coverage · Not right? Tell us
March Capital PartnersreportedSanta Monica
How we know: a partner's Signal profile · Not right? Tell us
RA CapitalreportedBoston
How we know: funding news · press coverage · Not right? Tell us
Vivo CapitalreportedPalo Alto · $10M – $50M
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$71M disclosed across 3 rounds · 2018–2022
- $40MSeries CJun 2022 · 2 sourcesSource ↗
▶$20MraisedJan 2020 · 6 investors · Other Health CareRule 506(b)
▶$20MraisedJan 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel AbramsExecutive Officer, Director
- Shah MahendraDirector
- Warren LammertDirector
- Stephen FarrDirector
- Weston NicholsDirector
- Matthew HammondDirector
- Offering amount
- $35M
- Amount sold
- $20M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedMar 2019 · 4 investors · PharmaceuticalsRule 506(b)
▶$11MraisedMar 2019 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Warren LammertDirector
- Stephen FarrDirector
- Mahendra ShahDirector
- Daniel AbramsExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cerebral Therapeutics's investors?
- Cerebral Therapeutics's investors include Granite Point Capital, March Capital Partners, RA Capital, Vivo Capital.
- How much funding has Cerebral Therapeutics raised?
- Cerebral Therapeutics has disclosed $71M raised across 3 rounds.
- Where is Cerebral Therapeutics headquartered?
- Cerebral Therapeutics is headquartered in Aurora, US.


